Literature DB >> 12574375

Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.

Gary M Winslow1, Alan D Roberts, Marcia A Blackman, David L Woodland.   

Abstract

CD4 T cells are critical for resistance to Mycobacterium tuberculosis infection, but how effective T cell responses are maintained during chronic infection is not well understood. To address this question we examined the CD4 T cell response to a peptide from ESAT-6 during tuberculosis infection in the mouse. The ESAT-6(1-20)/IA(b)-specific CD4 T cell response in the lungs, mediastinal lymph nodes, and spleen reached maxima 3-4 wk postinfection, when the bacteria came under the control of the immune response. Once chronic infection was established, the relative frequencies of Ag-specific CD4 T cells were maintained at nearly constant levels for at least 160 days. ESAT-6(1-20)/IA(b)-specific CD4 T cells that responded in vitro expressed activation markers characteristic of chronically activated effector cells and used a limited Vbeta repertoire that was clonally stable in vivo for at least 12 wk. 5-Bromo-2-deoxyuridine incorporation studies indicated a relatively high rate of cell division among both total CD4 and ESAT-6(1-20)/IA(b)-specific CD4 T cells during acute infection, but the degree of 5-bromo-2-deoxyuridine incorporation by both the CD4 T cells and the Ag-specific cells declined at least 3-fold during chronic infection. The data indicate that the peripheral ESAT-6(1-20)/IA(b)-specific CD4 T cell response to M. tuberculosis is characterized during the acute phase of infection by a period of extensive proliferation, but once bacterial control is achieved, this is followed during chronic infection by an extended containment phase that is associated with a persistent response of activated, yet more slowly proliferating, T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574375     DOI: 10.4049/jimmunol.170.4.2046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Joanne Turner; Mercedes Gonzalez-Juarrero; Oliver C Turner; Ian M Orme
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

2.  CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype.

Authors:  I V Lyadova; S Oberdorf; M A Kapina; A S Apt; S L Swain; P C Sayles
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Authors:  Christina L Lancioni; Qing Li; Jeremy J Thomas; XueDong Ding; Bonnie Thiel; Michael G Drage; Nicole D Pecora; Assem G Ziady; Samuel Shank; Clifford V Harding; W Henry Boom; Roxana E Rojas
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

4.  Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination.

Authors:  Sang-Jun Ha; Su-Hyung Park; Hye-Ju Kim; Seung-Chul Kim; Hyang-Ju Kang; Eun-Gae Lee; Soon-Geon Kwon; Byong-Moon Kim; Sung-Hee Lee; Won-Bae Kim; Young-Chul Sung; Sang-Nae Cho
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Antigen display, T-cell activation, and immune evasion during acute and chronic ehrlichiosis.

Authors:  Bisweswar Nandi; Madhumouli Chatterjee; Kathryn Hogle; Maura McLaughlin; Katherine MacNamara; Rachael Racine; Gary M Winslow
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

6.  The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death.

Authors:  Carl G Feng; Lixin Zheng; Dragana Jankovic; André Báfica; Jennifer L Cannons; Wendy T Watford; Damien Chaussabel; Sara Hieny; Patricia Caspar; Pamela L Schwartzberg; Michael J Lenardo; Alan Sher
Journal:  Nat Immunol       Date:  2008-09-21       Impact factor: 25.606

7.  Ectopic activation of Mycobacterium tuberculosis-specific CD4+ T cells in lungs of CCR7-/- mice.

Authors:  Sofia Olmos; Sabriya Stukes; Joel D Ernst
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

8.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes.

Authors:  William W Reiley; Mark D Calayag; Susan T Wittmer; Jennifer L Huntington; John E Pearl; Jeffrey J Fountain; Cynthia A Martino; Alan D Roberts; Andrea M Cooper; Gary M Winslow; David L Woodland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

9.  Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children.

Authors:  Tom G Connell; Mary-Ann Davies; Christine Johannisen; Kathryn Wood; Sandy Pienaar; Katalin A Wilkinson; Robert J Wilkinson; Heather J Zar; David Beatty; Mark P Nicol; Nigel Curtis; Brian Eley
Journal:  BMC Infect Dis       Date:  2010-05-27       Impact factor: 3.090

10.  In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity.

Authors:  Shabaana A Khader; Javier Rangel-Moreno; Jeffrey J Fountain; Cynthia A Martino; William W Reiley; John E Pearl; Gary M Winslow; David L Woodland; Troy D Randall; Andrea M Cooper
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.